[en] A 5-year-old girl presented with acute nocturnal episodes of loss of consciousness following abdominal pain and crying. Epilepsy was primarily diagnosed but the course of the disease was suggestive of pulmonary hypertension. An adapted invasive assessment of pulmonary pressure and pharmacological challenge allowed for diagnosing vasoreactive pulmonary arterial hypertension. Initial treatment with sildenafil was not effective. Thus, calcium channel blockers were introduced when positive vasoreactivity was confirmed and permitted to stop the occurrence of the syncope and dramatically improved clinical status. At 2 years follow-up she is well without any complaint and in functional class I. Echocardiography shows a slightly enlarged but not hypertrophied right ventricle with a nearly normalized estimated right ventricular pressure. The last catheterization shows subnormal values of pulmonary arterial pressure (mean pulmonary artery pressure: 24 mmHg) and pulmonary vascular resistance (5, 4 Wood units(*)m(2)), normalizing with inhaled Nitric Oxide (mean pulmonary artery pressure of 14 mmHg and pulmonary vascular resistance of 1.5 Wood units(*)m(2)). Vasoreactive pulmonary arterial hypertension is a rare entity in children but it should not be misdiagnosed with seizures due to the presence of syncopal episodes. According to current knowledge, this form seems to have a better prognosis than non-reactive pulmonary arterial hypertension and the treatment of choice remains as calcium channel blockers. The management of this case was characterized by successive mishaps and potentially harmful mistakes and underscores the potential risk with pediatric PH evaluation in non-expert centers.
Disciplines :
Cardiovascular & respiratory systems Pediatrics
Author, co-author :
FARHAT, Nesrine ; Centre Hospitalier Universitaire de Liège - CHU / Lausanne University Hospital (CHUV), Geneva University Hospitals (HUG), University of Geneva, Geneva, Switzerland, > Département de Pédiatrie / Pediatric Cardiology Unit and Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique > Service de pédiatrie
Cools, Bjorn; University Hospital Leuven > Pediatric Cardiology
Gewillig, Marc; University Hospital Leuven > Pediatric Cardiology
Seghaye, Marie-Christine ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie cardiologique et pneumologique
Aggoun, Yacine; Lausanne University Hospital (CHUV), Geneva University Hospitals (HUG), University of Geneva, Geneva, Switzerland > Pediatric Cardiology Unit and Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique
Beghetti, Maurice; Lausanne University Hospital (CHUV), Geneva University Hospitals (HUG), University of Geneva, Geneva, Switzerland, > Pediatric Cardiology Unit and Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique
Language :
English
Title :
Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls.
Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. (2015) 132:2037-99. doi: 10.1161/CIR.0000000000000329
Berger RM, Beghetti M, Humpl T, Raskob GE, Ivy DD, Jing Z-C, et al. Clinical features of paediatric pulmonary hypertension: a registry study. The Lancet. (2012) 379:537-46. doi: 10.1016/S0140-6736(11)61621-8
Hansmann G, Apitz C, Abdul-Khaliq H, Alastalo T-P, Beerbaum P, Bonnet D, et al. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European paediatric pulmonary vascular disease network, endorsed by ISHLT and DGPK. Heart Br Card Soc. (2016) 102(Suppl. 2):ii86-100. doi: 10.1136/heartjnl-2015-309132
Douwes JM, Humpl T, Bonnet D, Beghetti M, Ivy DD, Berger RMF, et al. Acute vasodilator response in pediatric pulmonary arterial hypertension: current clinical practice from the TOPP registry. J Am Coll Cardiol. (2016) 67:1312-23. doi: 10.1016/j.jacc.2016.01.015
Apitz C, Hansmann G, Schranz D. Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European paediatric pulmonary vascular disease network, endorsed by ISHLT and DGPK. Heart. (2016) 102(Suppl. 2):ii23-9. doi: 10.1136/heartjnl-2014-307340
Beghetti M, Berger RMF. The challenges in paediatric pulmonary arterial hypertension. Eur Respir Rev. (2014) 23:498-504. doi: 10.1183/09059180.00007714
Barst RJ, Ertel SI, Beghetti M, Ivy DD. Pulmonary arterial hypertension: a comparison between children and adults. Eur Respir J. (2011) 37:665-77. doi: 10.1183/09031936.00056110
Beghetti M, Haworth SG, Bonnet D, Barst RJ, Acar P, Fraisse A, et al. Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study. Br J Clin Pharmacol. (2009) 68:948-55. doi: 10.1111/j.1365-2125.2009.03532.x
Lador F, Sekarski N, Beghetti M. Treating pulmonary hypertension in pediatrics. Expert Opin Pharmacother. (2015) 16:711-26. doi: 10.1517/14656566.2015.1013937
Beghetti M, Fasnacht M. Hypertension artérielle pulmonaire de l'enfant: dépistage et traitement. (2004) 15:3.
Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. (2009) 34:888-94. doi: 10.1183/09031936.00145608
Apitz C, Zimmermann R, Kreuder J, Jux C, Latus H, Pons-Kühnemann J, et al. Assessment of pulmonary endothelial function during invasive testing in children and adolescents with idiopathic pulmonary arterial hypertension. J Am Coll Cardiol. (2012) 60:157-64. doi: 10.1016/j.jacc.2012.04.010
Douwes JM, van Loon RLE, Hoendermis ES, Vonk-Noordegraaf A, Roofthooft MTR, Talsma MD, et al. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. Eur Heart J. (2011) 32:3137-46. doi: 10.1093/eurheartj/ehr282
Limsuwan A, Khowsathit P. Assessment of pulmonary vasoreactivity in children with pulmonary hypertension. Curr Opin Pediatr. (2009) 21:594-9. doi: 10.1097/MOP.0b013e32832ff3d2
Saji T. Update on pediatric pulmonary arterial hypertension. Circ J. (2013) 77:2639-50. doi: 10.1253/circj.CJ-13-1180
Fraisse A, Jais X, Schleich J-M, di Filippo S, Maragnès P, Beghetti M, et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis. (2010) 103:66-74. doi: 10.1016/j.acvd.2009.12.001
Zijlstra WMH, Douwes JM, Rosenzweig EB, Schokker S, Krishnan U, Roofthooft MTR, et al. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies. J Am Coll Cardiol. (2014) 27 63:2159-69. doi: 10.1016/j.jacc.2014.02.575
Tonelli AR, Alnuaimat H, Mubarak K. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med. (2010) 104:481-96. doi: 10.1016/j.rmed.2009.11.015
Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. (2016) 37:67-119. doi: 10.1093/eurheartj/ehv317
Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, et al. Six-minute walk test in children and adolescents. J Pediatr. (2007) 150:395-9.e2. doi: 10.1016/j.jpeds.2006.12.052
Ploegstra M-J, Zijlstra WMH, Douwes JM, Hillege HL, Berger RMF. Prognostic factors in pediatric pulmonary arterial hypertension: a systematic review and meta-analysis. Int J Cardiol. (2015) 184:198-207. doi: 10.1016/j.ijcard.2015.01.038
Kopec G, Waligóra M, Tyrka A, Komar M, Herman N, Podolec P. Clinical response to calcium channel blockers in a hemodynamically unstable patient with reactive idiopathic pulmonary arterial hypertension. Arch Med Sci. (2017) 2:504-6. doi: 10.5114/aoms.2017.65230